» Articles » PMID: 32851071

Discovery and Validation of a CT-Based Radiomic Signature for Preoperative Prediction of Early Recurrence in Hypopharyngeal Carcinoma

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2020 Aug 28
PMID 32851071
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: In the clinical management of hypopharyngeal squamous cell carcinoma (HSCC), preoperative identification of early recurrence (≤2 years) after curative resection is essential. Thus, we aimed to develop a CT-based radiomic signature to predict early recurrence in HSCC patients preoperatively.

Methods: In total, 167 HSCC patients who underwent partial surgery were enrolled in this retrospective study and divided into two groups, i.e., the training cohort ( = 133) and the validation cohort ( = 34). Each individual was followed up for at least for 2 years. Radiomic features were extracted from CT images, and the radiomic signature was built with the least absolute shrinkage and selection operator (LASSO) logistic regression (LR) model. The associations of preoperative clinical factors with early recurrence were evaluated. A radiomic signature-combined model was built, and the area under the curve (AUC) was used to explore their performance in discriminating early recurrence.

Results: Among the 1415 features, 335 of them were selected using the variance threshold method. Then, the SelectKBest method was further used for the selection of 31 candidate features. Finally, 11 out of 31 optimal features were identified with the LASSO algorithm. In the LR classifier, the AUCs of the training and validation sets in discriminating early recurrence were 0.83 (95% CI: 0.76-0.90) (sensitivity 0.8 and specificity 0.83) and 0.83 (95% CI: 0.67-0.99) (sensitivity 0.69 and specificity 0.71), respectively.

Conclusions: Using the radiomic signature, we developed a radiomic signature to preoperatively predict early recurrence in patients with HSCC, which may serve as a potential noninvasive tool to guide personalized treatment.

Citing Articles

Radiomics analysis for the prediction of locoregional recurrence of locally advanced oropharyngeal cancer and hypopharyngeal cancer.

Wu T, Liu Y, Chen J, Chen T, Ko C, Lin C Eur Arch Otorhinolaryngol. 2023; 281(3):1473-1481.

PMID: 38127096 DOI: 10.1007/s00405-023-08380-4.


Radiomics in Hypopharyngeal Cancer Management: A State-of-the-Art Review.

Chiesa-Estomba C, Mayo-Yanez M, Guntinas-Lichius O, Vander-Poorten V, Takes R, de Bree R Biomedicines. 2023; 11(3).

PMID: 36979783 PMC: 10045560. DOI: 10.3390/biomedicines11030805.


MRI Radiomics for Predicting Survival in Patients with Locally Advanced Hypopharyngeal Cancer Treated with Concurrent Chemoradiotherapy.

Siow T, Yeh C, Lin G, Lin C, Wang H, Liao C Cancers (Basel). 2022; 14(24).

PMID: 36551604 PMC: 9775984. DOI: 10.3390/cancers14246119.


Multimodal Imaging and Phototherapy of Cancer and Bacterial Infection by Graphene and Related Nanocomposites.

Gollavelli G, Ghule A, Ling Y Molecules. 2022; 27(17).

PMID: 36080351 PMC: 9457605. DOI: 10.3390/molecules27175588.


[Research progress in CT-based radiomics constructing hypopharyngeal cancer and multisystem tumor prediction model].

Wang Y, Lei D Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022; 36(2):158-162.

PMID: 35172558 PMC: 10128304. DOI: 10.13201/j.issn.2096-7993.2022.02.018.


References
1.
Parmar C, Leijenaar R, Grossmann P, Velazquez E, Bussink J, Rietveld D . Radiomic feature clusters and prognostic signatures specific for Lung and Head & Neck cancer. Sci Rep. 2015; 5:11044. PMC: 4937496. DOI: 10.1038/srep11044. View

2.
Hesketh R, Zhu A, Oklu R . Radiomics and circulating tumor cells: personalized care in hepatocellular carcinoma?. Diagn Interv Radiol. 2014; 21(1):78-84. PMC: 4463354. DOI: 10.5152/dir.2014.14237. View

3.
Liu Z, Wang S, Dong D, Wei J, Fang C, Zhou X . The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges. Theranostics. 2019; 9(5):1303-1322. PMC: 6401507. DOI: 10.7150/thno.30309. View

4.
Mo X, Wu X, Dong D, Guo B, Liang C, Luo X . Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation. Eur Radiol. 2019; 30(2):833-843. DOI: 10.1007/s00330-019-06452-w. View

5.
Kumar V, Gu Y, Basu S, Berglund A, Eschrich S, Schabath M . Radiomics: the process and the challenges. Magn Reson Imaging. 2012; 30(9):1234-48. PMC: 3563280. DOI: 10.1016/j.mri.2012.06.010. View